S&P 500
3,298.46+51.87(+1.60%)Nasdaq
10,913.56+241.29(+2.26%)Russell 2000
1,474.91+23.09(+1.59%)
BIOLASE, Inc. (BIOL)
Chart Events
Performance Outlook
| Previous Close | 0.2856 |
| Open | 0.2900 |
| Bid | 0.2810 x 800 |
| Ask | 0.2851 x 800 |
| Day's Range | 0.2800 - 0.2900 |
| 52 Week Range | 0.2100 - 1.0700 |
| Volume | 1,105,841 |
| Avg. Volume | 7,228,132 |
| Market Cap | 25.813M |
| Beta (5Y Monthly) | 1.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6650 |
| Earnings Date | Aug 13, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 24, 2005 |
| 1y Target Est | 1.63 |
- PR Newswire
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from the McGuire Institute comparing periodontal flap surgery to BIOLASE's REPAIR Perio laser protocol in managing periodontitis.
- PR Newswire
BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright 22nd Annual Global Investor Conference on Wednesday, September 16, 2020 at 11:00 am Pacific Time (2:00 pm ET).
- PR Newswire
BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements at the Colliers & Co. Institutional Investor Conference on Thursday, September 10, 2020. The conference will feature virtual one-on-one meetings with the BIOLASE' executives and institutional investors are invited to request meeting times at tkehrli@evcgroup.com or through their Colliers representative.
